BCAP31-related syndrome: The first de novo report

• Published in: European journal of medical genetics 2020-02, Vol.63 (2), p.103732-103732, Article 103732
• Main Authors: Rinaldi, Berardo, Van Hoof, Evelien, Corveleyn, Anniek, Van Cauter, Annick, de Ravel, Thomy
• Format: Article
• Language: English
• Subjects: BCAP31; Central hypomyelination; DDCH syndrome; Dystonia; Hearing loss; Xq28
• ISSN: 1769-7212; 1878-0849
• DOI: 10.1016/j.ejmg.2019.103732

Pathogenic variants in the BCAP31 gene have recently been associated with a severe congenital neurological phenotype, named DDCH after its key features: deafness, dystonia and central hypomyelination. BCAP31 is located at the Xq28 chromosomal region and only male individuals are currently known to be affected, the pathogenic variant being usually transmitted by healthy mothers. Here, we describe a three-year-old male child referred for severe developmental delay, failure to thrive, hearing loss and dyskinetic movements. After a conventional diagnostic workflow, including a normal array-CGH, a tentative diagnosis of dyskinetic cerebral palsy was retained. Clinical exome sequencing in the trio identified a small intragenic deletion in exon 8 of BCAP31, c.709_721del (p.Val237Trpfs*69), originated de novo and not previously reported. Based on the ACMG variant classification, this variant is predicted to be ‘likely pathogenic’. Given the consistent phenotypical overlap with the subjects already ascertained with DDCH, we considered this variant to be clinically relevant for this child and causative of his condition.